A Proposed Settlement has been reached in a class action lawsuit in the United States District Court, Eastern District of California, (the “Action”) that may affect your rights. The Plaintiff claims that Zicam LLC and Matrixx Initiatives,
The class is defined as all residents of the United States of America who purchased any of the following Zicam products in the United States from February 15, 2011 through June 5, 2018: RapidMelts Original, RapidMelts Ultra, Oral Mist, Ultra
Because this product is a "homeopathic" over-the-counter drug, it is exempt from a number of the requirements ordinarily applicable to OTC drug products, provided it conforms to the standards of the Homeopathic Pharmacopeia of the United States
Du wurdest vorübergehend blockiert Facebook Browser wird nicht unterstützt Du verwendest einen Browser, der von Facebook nicht unterstützt wird. Wir haben dich daher an eine einfachere Version weitergeleitet, um dir das bestmögliche Erlebnis
Zicam has agreed to pay $16 million as part of a settlement for a lawsuit alleging the company made false and misleading statements about certain Zicam products. Customers who bought